Please assess the completion status of the following clinical trial:

Trial Title: A Health Intervention to Prevent Depression Hepatitis C Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed with Hepatitis C and prescribed IFN-α~* Ability to understand and willingness to provide written informed consent.~* Willing to provide contact information.~* Medical clearance with protocol-defined stress testing (in accordance with American College of Sports Medicine (ACSM) guidelines) from protocol approved medical personnel. Details of guidelines and related testing protocol are provided in the study Manual of Procedures.~* Able to comprehend and communicate in English.~Exclusion Criteria:~* Have a medical condition contraindicating exercise participation~* Are currently physically active - defined as moderate intensity physical activity on 3 or more days per week for the last month~* Have been diagnosed with current Major Depressive Disorder or are currently receiving antidepressant medication treatment (including SSRIs and SNRIs)~* Currently considered a high suicide risk and/or high risk for being unable to complete the study due to the need for psychiatric hospitalization, suicide attempts or suicidality, significant self-mutilation, or other self-injurious or destructive behavior based on the judgment of the site PI, medical personnel, or designee.~* Pregnancy.~* Current psychotic disorder. Other comorbid psychiatric diagnosis that, in the investigator's judgment, will pose a safety issue or make it difficult for the participant to understand or complete the intervention.~* Anticipated circumstances over the 6-month course of the trial that would render the participant unlikely to complete the study in the judgment of the PI or designee.~* Any reason not listed herein yet, determined by the PI, medical personnel, or designee that constitutes good clinical practice and that would in the opinion of the PI, medical personnel, or designee make participation in the study hazardous.~* Are currently enrolled in another research study, and participation in that study contraindicates participation in the current study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Health Education (Type: ACTIVE_COMPARATOR): Participants will three attend heath education sessions per week for 26 weeks.
- Exercise (Type: EXPERIMENTAL): Participants will engage in a public health dose of moderate-to-vigorous aerobic exercise for 26 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).